Related references
Note: Only part of the references are listed.2019 Novel coronavirus: where we are and what we know
Zhangkai J. Cheng et al.
INFECTION (2020)
Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis
Sheng Zhang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Likelihood of survival of coronavirus disease 2019 Comment
Shigui Ruan
LANCET INFECTIOUS DISEASES (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Steven Sanche et al.
EMERGING INFECTIOUS DISEASES (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Jennifer Harcourt et al.
EMERGING INFECTIOUS DISEASES (2020)
A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis
Christina B. Karsten et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation
Stephanie Fischinger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
Ivy Widjaja et al.
EMERGING MICROBES & INFECTIONS (2019)
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire et al.
CELL (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Role of Fc-FcγR interactions in the antitumor activity of therapeutic antibodies
Bryan C. Barnhart et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Distribution of FcRn Across Species and Tissues
Sari Latvala et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
Eric P. Brown et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Human monoclonal antibodies as candidate therapeutics against emerging viruses
Yujia Jin et al.
FRONTIERS OF MEDICINE (2017)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Alison E. Mahan et al.
PLOS PATHOGENS (2016)
How antibodies alter the cell entry pathway of dengue virus particles in macrophages
Nilda V. Ayala-Nunez et al.
SCIENTIFIC REPORTS (2016)
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Amy W. Chung et al.
CELL (2015)
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
Yan Li et al.
CELL RESEARCH (2015)
Fc receptors in antibody-dependent enhancement of viral infections
Adam Taylor et al.
IMMUNOLOGICAL REVIEWS (2015)
Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Sheng-Fan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Ming Shum Yip et al.
VIROLOGY JOURNAL (2014)
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Maya K. Leabman et al.
MABS (2013)
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
Eric P. Brown et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Crosstalk between Human IgG Isotypes and Murine Effector Cells
Marije B. Overdijk et al.
JOURNAL OF IMMUNOLOGY (2012)
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Margaret E. Ackerman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent FcγR Pathway
Martial Jaume et al.
JOURNAL OF VIROLOGY (2011)
Neonatal Fc Receptor: From Immunity to Therapeutics
Timothy T. Kuo et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
Gregory L. Moore et al.
MABS (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
FcγRIV:: A novel FcR with distinct IgG subclass specificity
F Nimmerjahn et al.
IMMUNITY (2005)
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
ZY Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications
A Takada et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Share Paper
